ZVRA Net Margin
42.82%TTM
Period ending:
ZVRA FY Net Margin%
141.17%-509.86%
2012-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.
ZVRA net margin history
Net income as a percentage of revenue. The available annual fiscal periods series contains 14 observations from Dec 31, 2012 to Dec 31, 2025.
| Period ending | Net Margin |
|---|---|
| 78.1713% | |
| -446.8533% | |
| -167.6887% | |
| -263.478% | |
| -29.8604% | |
| -96.0265% | |
| -190.9962% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |
Compare net margin
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) net margin
- Bridgebio Pharma Inc (BBIO) net margin
- Brightspring Health Services Inc (BTSG) net margin
- Madrigal Pharmaceuticals Inc (MDGL) net margin
- Ensign Group Inc (ENSG) net margin
- Glaukos Corp (GKOS) net margin
- Krystal Biotech Inc (KRYS) net margin
- Twist Bioscience Corp (TWST) net margin
Compare all covered stocks by net margin →
All ZVRA financial metrics · ZVRA stock overview · How to interpret financial metrics
